Recombinant IL23A (Guselkumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target
- IL23A (Guselkumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This IL23A (Guselkumab Biosimilar) antibody is un-conjugated
- Application
- ELISA
- Purpose
- Guselkumab Biosimilar - Anti-IL23A mAb
- Characteristics
- Antibody Type: IgG1-lambda
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG1 lambda
-
anti-IL23A (Guselkumab Biosimilar) (Glu239Asp-Mutant), (Met241Leu-Mutant) antibody
Research Grade Reactivity: Human ELISA Host: Humanized Monoclonal unconjugated
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- IL23A (Guselkumab Biosimilar)
- Target Type
- Biosimilar
- Background
-
CNTO-1959
Guselkumab is a human IgG1 lambda monoclonal antibody that targets interleukin-23. IL-23 is an inflammatory cytokine that is reponsible for the activation of the CD4+ T-helper (Th17) cell pathway in the inflammatory cascade that induces psoriatic plaque formation. Guselkumab has been used to treat psoriasis. - CAS-No
- 1350289-85-8
-
You are here:
